Clinical Spine Surgery published the study.
Here are five things to know:
1. The study tested CLARIX 100 for lumbar microdiscectomy surgery.
2. D. Greg Anderson, MD, of Philadelphia-based Rothman Institute, led the study, which include 80 patients.
3. Forty patients received CLARIX 100, which surgeons placed in the annular defect when removing the disc fragment during microdiscectomy. The other 40 patients received standard care without adjunctive tissue placement.
4. Researchers found CLARIX 100 patients saw greater pain reduction and improved daily function at six weeks post-surgery. These patients also saw improvement through the two-year follow up.
5. While 7.5 percent of the control group experienced re-herniation, no CLARIX 100 patients had re-herniation.
More articles on spine:
Spinal decompression vs. fusion: 5 key notes for workers compensation return to work
Dr. Kamal R. Woods, Kern Singh & more: 7 spine, neurosurgeons in the news
Drs. Kamal Woods, David Duffner & more: 4+ spine surgeons & neurosurgeons recently receiving honors — July 7, 2017
